Structure revision of tricholomenyn B, an antimitotic geranylcyclohexenone rediscovered as a bitter and antibacterial substance, from a basidiomycete Tricholoma japonicum (Shiro-shimeji)

J Antibiot (Tokyo). 2024 Sep;77(9):634-637. doi: 10.1038/s41429-024-00746-y. Epub 2024 May 31.

Abstract

Tricholomenyn B, an antimitotic geranylcyclohexenone originally discovered from a basidiomycete Tricholoma acerbum, was isolated as a bitter and antibacterial constituent from fruiting bodies of T. japonicum. Careful comparison of NMR, MS, and other physicochemical properties of the isolated substance with the literature values revised a previously proposed macrolide structure 1 to a macrodiolide 2. Compound 2 was perceived bitter at a minimum dose of 37.5 μg, showed weak antimicrobial activity against Kocuria rhizophila and Staphylococcus aureus, and was marginally cytotoxic (IC50 2.6 µM) against P388 murine leukemia cells.

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / isolation & purification
  • Anti-Bacterial Agents* / pharmacology
  • Antimitotic Agents / chemistry
  • Antimitotic Agents / isolation & purification
  • Antimitotic Agents / pharmacology
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology
  • Basidiomycota* / chemistry
  • Cell Line, Tumor
  • Leukemia P388 / drug therapy
  • Magnetic Resonance Spectroscopy
  • Mice
  • Microbial Sensitivity Tests*
  • Molecular Structure
  • Staphylococcus aureus* / drug effects

Substances

  • Anti-Bacterial Agents
  • Antimitotic Agents
  • Antineoplastic Agents